TW200708507A - A process for the preparation of tetrazolyltetrahydrocyclopentapyrazoles - Google Patents

A process for the preparation of tetrazolyltetrahydrocyclopentapyrazoles

Info

Publication number
TW200708507A
TW200708507A TW095114375A TW95114375A TW200708507A TW 200708507 A TW200708507 A TW 200708507A TW 095114375 A TW095114375 A TW 095114375A TW 95114375 A TW95114375 A TW 95114375A TW 200708507 A TW200708507 A TW 200708507A
Authority
TW
Taiwan
Prior art keywords
preparation
tetrazolyltetrahydrocyclopentapyrazoles
cyclopentane
solvate
hydrate
Prior art date
Application number
TW095114375A
Other languages
English (en)
Inventor
Michael Stewart Ashwood
Matthew Bio
Edward Cleator
David Hands
Faye Julia Sheen
Robert Darrin Wilson
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0508515A external-priority patent/GB0508515D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of TW200708507A publication Critical patent/TW200708507A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW095114375A 2005-04-28 2006-04-21 A process for the preparation of tetrazolyltetrahydrocyclopentapyrazoles TW200708507A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0508515A GB0508515D0 (en) 2005-04-28 2005-04-28 Chemical process
US67633405P 2005-04-29 2005-04-29

Publications (1)

Publication Number Publication Date
TW200708507A true TW200708507A (en) 2007-03-01

Family

ID=36608773

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095114375A TW200708507A (en) 2005-04-28 2006-04-21 A process for the preparation of tetrazolyltetrahydrocyclopentapyrazoles

Country Status (5)

Country Link
US (1) US8168799B2 (zh)
EP (1) EP1877402A1 (zh)
AR (1) AR053593A1 (zh)
TW (1) TW200708507A (zh)
WO (1) WO2006114581A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050483A1 (es) 2003-10-31 2005-08-25 Arena Pharm Inc Derivados de tetrazol de formula (i), sus composiciones farmaceuticas y procesos para producir composiciones farmaceuticas
GB0515926D0 (en) 2005-08-03 2005-09-07 Merck Sharp & Dohme Chemical process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134155A (en) 1991-08-08 1992-07-28 Ortho Pharmaceutical Corporation Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-coA reductase inhibitors
PE20050483A1 (es) 2003-10-31 2005-08-25 Arena Pharm Inc Derivados de tetrazol de formula (i), sus composiciones farmaceuticas y procesos para producir composiciones farmaceuticas
GB0515926D0 (en) 2005-08-03 2005-09-07 Merck Sharp & Dohme Chemical process

Also Published As

Publication number Publication date
AR053593A1 (es) 2007-05-09
US8168799B2 (en) 2012-05-01
WO2006114581A1 (en) 2006-11-02
EP1877402A1 (en) 2008-01-16
US20100174091A1 (en) 2010-07-08

Similar Documents

Publication Publication Date Title
PH12014502771A1 (en) Nucleoside phosphoramidate prodrugs
TN2010000131A1 (en) Polo-like kinase inhibitors
MY150542A (en) Cmet inhibitors
IN2012DN02751A (zh)
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
PH12013500365A1 (en) Anti-infective agents and uses thereof
MX2009013592A (es) Proceso para la preparacion de pirazoles.
MX2010002902A (es) Pirimidinas anti-infecciosas y usos de las mismas.
MX2009014104A (es) Metodos para sintetizar cinacalcet y sales del mismo.
TW201129564A (en) Diphenylpyrazolopyridine derivatives, preparation thereof and therapeutic use thereof
PT2421879E (pt) Novos 7-deazapurina nucleósidos para utilizações terapêuticas
MX2010004669A (es) Proceso para la preparacion de derivados de isoindol asi como tambien un proceso para la preparacion de sus intermediarios.
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
MX2011007998A (es) Nuevos herbicidas.
MY161132A (en) Novel herbicides
MX2013000295A (es) Procedimiento de preparacion de un inhibidor especifico de la trombina.
MX2012013332A (es) Preparacion de intermediarios de posaconazol.
UA95972C2 (ru) Аминопиридиновые производные с селективной ингибирующей активностью в отношении авроры а
UA102289C2 (ru) Гербициды, полученные из циклопентадиона
GEP20125512B (en) Process for synthesis of agomelatin
MX337320B (es) Análogos halogenados de agentes anti-fibroticos.
MY152557A (en) 3-aminocyclopentanecarboxamides as chemokine receptor modulators
MX2012006524A (es) Proceso para la sintesis de compuestos intermedios de utilidad para preparar compuestos sustituidos de indazol y azaindol.
MX2013000294A (es) Intermedios y procedimiento de preparación de un inhibidor específico de la trombina.